Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69

被引:74
作者
Llera, AS
Viedma, F
Sánchez-Madrid, F
Tormo, J [1 ]
机构
[1] Univ Autonoma Madrid, Natl Biotechnol Ctr, Dept Macromol Struct, E-28049 Madrid, Spain
[2] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Estudios Inmunidad Humoral, RA-1113 Buenos Aires, DF, Argentina
[3] Univ Autonoma Madrid, Hosp Princesa, Serv Immunol, Madrid 28006, Spain
关键词
D O I
10.1074/jbc.M008573200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD69,: one of the earliest specific antigens acquired during lymphoid activation, acts as a signal-transducing receptor,involved in cellular activation events, including proliferation and induction of specific genes. CD69 belongs:to a family of receptors that modulate the immune response and whose genes are clustered in the natural killer (NK) gene complex. The extracellular portion of these receptors represent a subfamily of C-type lectin-like domains (CTLDs), which are divergent from true C-type lectins and are referred to as NK-cell domains (NKDs). We have determined the three-dimensional:Structure of human CD69 NKD in two different crystal forms. CD69 NKD adopts the canonical CTLD fold but lacks:the features involved in Ca2+ and carbohydrate binding by C-type lectins. CD69 NKD dimerizes noncovalently, both in solution and in crystalline state. The dimer interface consists of a hydrophobic, loosely packed core,:surrounded by polar interactions, including an interdomain beta sheet. The intersubunit core shows certain structural plasticity that may facilitate conformational: rearrangements for binding to ligands. The surface equivalent to the binding site of other members of the CTLD superfamily reveals a hydrophobic patch surrounded by conserved charged residues that probably constitutes:the CD69 ligand-binding site.
引用
收藏
页码:7312 / 7319
页数:8
相关论文
共 61 条
[1]  
BAJORATH J, 1994, J BIOL CHEM, V269, P32457
[2]  
Bates EEM, 1999, J IMMUNOL, V163, P1973
[3]   Early signaling via inhibitory and activating NK receptors [J].
Bléry, M ;
Olcese, L ;
Vivier, E .
HUMAN IMMUNOLOGY, 2000, 61 (01) :51-64
[4]   Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis [J].
Borrego, F ;
Ulbrecht, M ;
Weiss, EH ;
Coligan, JE ;
Brooks, AG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) :813-818
[5]   Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors [J].
Boyington, JC ;
Riaz, AN ;
Patamawenu, A ;
Coligan, JE ;
Brooks, AG ;
Sun, PD .
IMMUNITY, 1999, 10 (01) :75-82
[6]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[7]   The natural killer gene complex: A genetic basis for understanding natural killer cell function and innate immunity [J].
Brown, MG ;
Scalzo, AA ;
Matsumoto, K ;
Yokoyama, WM .
IMMUNOLOGICAL REVIEWS, 1997, 155 :53-65
[8]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[9]   TRIGGERING OF T-CELL PROLIFERATION THROUGH AIM, AN ACTIVATION INDUCER MOLECULE EXPRESSED ON ACTIVATED HUMAN-LYMPHOCYTES [J].
CEBRIAN, M ;
YAGUE, E ;
RINCON, M ;
LOPEZBOTET, M ;
DELANDAZURI, MO ;
SANCHEZMADRID, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (05) :1621-1637
[10]   Recombinant soluble human CD69 dimer produced in Escherichia coli:: Reevaluation of saccharide binding [J].
Childs, RA ;
Galustian, C ;
Lawson, AM ;
Dougan, G ;
Benwell, K ;
Frankel, C ;
Feizi, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (01) :19-23